Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PAVmed Inc PAVMZ


Primary Symbol: PAVM

Healthcare Medical Devices
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device... see more

Recent & Breaking News (NDAQ:PAVM)

PAVmed Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement

PR Newswire June 28, 2023

PAVmed to Participate in Healthcare Virtual Conference Presented by Maxim Group LLC

PR Newswire June 14, 2023

Lucid Diagnostics Launches First EsoGuard® Mobile Test Unit

PR Newswire June 5, 2023

PAVmed Digital Health Subsidiary, Veris Health, Joins Cancer Moonshot's CancerX Partnership as Founding Member

PR Newswire June 2, 2023

PAVmed Provides Business Update and First Quarter Financial Results

PR Newswire May 16, 2023

Lucid Diagnostics Provides Business Update and First Quarter Financial Results

PR Newswire May 15, 2023

Lucid Diagnostics and Collaborators Present New EsoGuard® and EsoCheck® Data at Digestive Disease Week® (DDW) 2023 Conference

PR Newswire May 11, 2023

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 16, 2023

PR Newswire May 5, 2023

PAVmed to Hold a Business Update Conference Call and Webcast on May 17, 2023

PR Newswire May 5, 2023

PAVmed Digital Health Subsidiary, Veris Health, Appoints Gary Manning as President

PR Newswire April 25, 2023

PAVmed Digital Health Subsidiary, Veris Health, to Present Comprehensive Meta-analysis on Impact of Remote Patient Monitoring in Oncology at HIMSS

PR Newswire April 19, 2023

Lucid Diagnostics to Present at 22nd Annual Needham Virtual Healthcare Conference

PR Newswire April 17, 2023

Lucid Diagnostics Provides Update on Newly Published Future Effective Medicare Local Coverage Determination on Molecular Testing for Detection of Esophageal Precancer and Cancer

PR Newswire March 31, 2023

PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2022 Financial Results

PR Newswire March 14, 2023

/C O R R E C T I O N -- Lucid Diagnostics/

PR Newswire March 14, 2023

Lucid Diagnostics Provides Business Update and Fourth Quarter and Full Year 2022 Financial Results

PR Newswire March 13, 2023

PAVmed to Hold a Business Update Conference Call and Webcast on March 15, 2023

PR Newswire March 3, 2023

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 14, 2023

PR Newswire March 3, 2023

PAVmed Digital Health Subsidiary Veris Health's Veris Cancer Care Platform(TM) Goes Live

PR Newswire February 28, 2023

Lucid Diagnostics Holds First #CheckYourFoodTube Precancer Testing Event

PR Newswire February 15, 2023